CYTK vs. AXTI
CYTK (Cytokinetics, Incorporated) and AXTI (AXT, Inc.) are both stocks. CYTK operates in Biotechnology (Healthcare), while AXTI operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, CYTK returned 24.23%/yr vs 39.98%/yr for AXTI. At a 0.15 correlation, their price movements are largely independent.
Performance
CYTK vs. AXTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CYTK achieves a 24.60% return, which is significantly lower than AXTI's 465.38% return. Over the past 10 years, CYTK has underperformed AXTI with an annualized return of 24.23%, while AXTI has yielded a comparatively higher 39.98% annualized return.
CYTK
- 1D
- 0.50%
- 1M
- 2.90%
- YTD
- 24.60%
- 6M
- 20.69%
- 1Y
- 144.13%
- 3Y*
- 31.00%
- 5Y*
- 28.83%
- 10Y*
- 24.23%
AXTI
- 1D
- 9.31%
- 1M
- -34.36%
- YTD
- 465.38%
- 6M
- 507.36%
- 1Y
- 4,923.91%
- 3Y*
- 204.32%
- 5Y*
- 53.72%
- 10Y*
- 39.98%
CYTK vs. AXTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CYTK Cytokinetics, Incorporated | 24.60% | 35.08% | -43.66% | 82.21% | 0.53% | 119.35% | 95.85% | 67.88% | -22.45% | -32.92% |
AXTI AXT, Inc. | 465.38% | 653.46% | -9.58% | -45.21% | -50.28% | -7.94% | 120.00% | -0.00% | -50.00% | 81.25% |
Correlation
The correlation between CYTK and AXTI is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2004 | 0.15 |
The correlation between CYTK and AXTI shifts across timeframes, from 0.08 (1 year) to 0.18 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
CYTK:
$9.76B
AXTI:
$4.93B
CYTK:
-$6.84
AXTI:
-$0.30
CYTK:
90.75
AXTI:
44.69
CYTK:
$105.82M
AXTI:
$95.89M
CYTK:
$95.60M
AXTI:
$20.46M
CYTK:
-$748.97M
AXTI:
-$7.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CYTK vs. AXTI — Risk / Return Rank
CYTK
AXTI
CYTK vs. AXTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and AXT, Inc. (AXTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CYTK | AXTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -33.83 | ||
| Sortino ratioReturn per unit of downside risk | -2.59 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.79 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | 9.66 | 112.78 | -103.12 |
| Martin ratioReturn relative to average drawdown | 21.25 | 347.98 | -326.73 |
Loading charts...
Drawdowns
CYTK vs. AXTI - Drawdown Comparison
The maximum CYTK drawdown since its inception was -97.09%, roughly equal to the maximum AXTI drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for CYTK and AXTI.
Loading charts...
Drawdown Indicators
| CYTK | AXTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.09% | -98.57% | +1.48% |
Max Drawdown (1Y)Largest decline over 1 year | -15.01% | -44.36% | +29.35% |
Max Drawdown (3Y)Largest decline over 3 years | -72.39% | -78.52% | +6.13% |
Max Drawdown (5Y)Largest decline over 5 years | -72.39% | -89.71% | +17.32% |
Max Drawdown (10Y)Largest decline over 10 years | -72.39% | -92.45% | +20.06% |
Current DrawdownCurrent decline from peak | -26.74% | -34.36% | +7.62% |
Average DrawdownAverage peak-to-trough decline | -75.95% | -82.24% | +6.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.81% | 14.35% | -7.54% |
Volatility
CYTK vs. AXTI - Volatility Comparison
The current volatility for Cytokinetics, Incorporated (CYTK) is 11.75%, while AXT, Inc. (AXTI) has a volatility of 46.68%. This indicates that CYTK experiences smaller price fluctuations and is considered to be less risky than AXTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CYTK | AXTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.75% | 46.68% | -34.93% |
Volatility (6M)Calculated over the trailing 6-month period | 33.22% | 114.70% | -81.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.13% | 138.47% | -77.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 70.19% | 96.68% | -26.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.02% | 83.07% | -15.05% |
Dividends
CYTK vs. AXTI - Dividend Comparison
Neither CYTK nor AXTI has paid dividends to shareholders.
Financials
CYTK vs. AXTI - Financials Comparison
This section allows you to compare key financial metrics between Cytokinetics, Incorporated and AXT, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CYTK and AXTI have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXTI has higher volatility (46.68%) compared to CYTK (11.75%). In terms of maximum drawdown, CYTK dropped -97.09% vs AXTI's -98.57%.
AXTI currently has the higher Sharpe Ratio (36.20 vs 2.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CYTK and AXTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer